These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms. Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353 [No Abstract] [Full Text] [Related]
25. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report. George S; Cowan C Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440 [No Abstract] [Full Text] [Related]
26. Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine. Hommers L; Scharl M; Hefner G; Hohner M; Fischer M; Pfuhlmann B; Deckert J; Unterecker S J Clin Psychopharmacol; 2018 Jun; 38(3):188-192. PubMed ID: 29620699 [TBL] [Abstract][Full Text] [Related]
27. Pregabalin in the treatment of schizophrenic anxiety. Schönfeldt-Lecuona C; Wolf RC; Osterfeld ND; Vasic N; Connemann BJ; Schmid M; Freudenmann RW Pharmacopsychiatry; 2009 May; 42(3):124-5. PubMed ID: 19452382 [No Abstract] [Full Text] [Related]
28. [New psychopharmacologic alternatives in treatment of schizophrenia]. Bryois C Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941 [TBL] [Abstract][Full Text] [Related]
29. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
30. Adjunctive ondansetron in schizophrenia--A pilot study. Hema T; Maran S; Subhashini G Asian J Psychiatr; 2016 Feb; 19():66-7. PubMed ID: 26957341 [No Abstract] [Full Text] [Related]
31. [Clozapine in treatment of neuropsychiatric diseases in the elderly]. Retz W; Rösler M; Sitzmann L; Becker T Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447 [TBL] [Abstract][Full Text] [Related]
33. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study. Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the bioequivalence of generic versus branded clozapine. Ereshefsky L; Glazer WM J Clin Psychiatry; 2001; 62 Suppl 5():25-7. PubMed ID: 11305845 [No Abstract] [Full Text] [Related]
36. New developments in the pharmacological treatment of schizophrenia. Kane JM Bull Menninger Clin; 1992; 56(1):62-75. PubMed ID: 1348197 [TBL] [Abstract][Full Text] [Related]
37. Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia. Pehlivanidis A; Spyropoulou AC; Tourkantonis A; Papadimitriou GN Clin Neuropharmacol; 2010 May; 33(3):168. PubMed ID: 20502137 [No Abstract] [Full Text] [Related]
38. Seizure on low-dose clozapine. Ravasia S; Dickson RA Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281 [No Abstract] [Full Text] [Related]
39. Clozapine-Associated Kidney Injury Complicated by Lithium Toxicity: A Case Report and Literature Review. DeLucia B J Clin Psychopharmacol; 2019; 39(3):273-275. PubMed ID: 30939593 [No Abstract] [Full Text] [Related]
40. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Cook B; Hoogenboom G Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]